معرفی
Shoohb Alassadi serves as an Associate Lecturer at the Sydney Pharmacy School within the Faculty of Medicine and Health at the University of Sydney, actively contributing to pharmaceutical education and research.
She completed her doctoral studies with a PhD thesis titled Determination of the stability and physical compatibility of 10 frequently prescribed paediatric IV medications in glucose and saline fluid, supervised by Jessica Pace, Nial Wheate, Lifeng Kang, and Veysel Kayser.
Her research specializes in Medicinal Chemistry and Pharmaceutical Sciences, with concentrated expertise in drug stability analysis for pediatric intravenous medications and platinum-based anticancer agents. She investigates chemical properties, formulation compatibility, and clinical translation of oncology therapeutics, aiming to optimize drug safety profiles for vulnerable patient populations.
Her 2022 publication in Dalton Transactions establishes her focus on platinum-based anticancer drug mechanisms, revealing trends toward molecular-level analysis of drug degradation pathways and clinical application challenges. This work complements her foundational research on pediatric medication stability, indicating a cohesive trajectory in pharmaceutical optimization.
No scientific awards or honors were documented in available materials.
While her supervisory activities for current students remain unreported, her own doctoral training under prominent faculty demonstrates rigorous research mentorship experience. No grant funding details were publicly accessible.
Her work integrates closely with pharmaceutical chemistry laboratories at the University of Sydney, though specific team structures were not disclosed in source materials.
